Thursday, February 27, 2014
This week in
Publication and contact
Categorization of breast
cancers based on expression of vitamin D
receptor and estrogen
A breast cancer
classification system based on expression of three nuclear hormone receptors
could help guide prognosis and treatment of the disease. An analysis of normal
luminal breast cell differentiation identified four luminal breast cancer
categories based on the bimodal expression of VDRs, androgen receptors and
estrogen receptors. In samples from patients with breast cancer, the
categories correlated with disease outcome, with tumors that did not express
the receptors (HR0) having the worst prognosis and tumors expressing all
three receptors (HR3) having the best. Next steps include using the system to
develop a prognostic test.
Published online Feb. 27, 2014
Patent application filed;
available for licensing as a diagnostic or prognostic test
Santagata, S. et al. J.
Clin. Invest.; published online Jan. 27, 2014;
Contact: Sandro Santagata, Brigham and Women's Hospital and Harvard
Medical School, Boston, Mass.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]